BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15845451)

  • 1. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs.
    Sun CM; Deriaud E; Leclerc C; Lo-Man R
    Immunity; 2005 Apr; 22(4):467-77. PubMed ID: 15845451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells.
    Zhang X; Deriaud E; Jiao X; Braun D; Leclerc C; Lo-Man R
    J Exp Med; 2007 May; 204(5):1107-18. PubMed ID: 17485512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
    Li Y; Ishii K; Hisaeda H; Hamano S; Zhang M; Nakanishi K; Yoshimoto T; Hemmi H; Takeda K; Akira S; Iwakura Y; Himeno K
    Gene Ther; 2004 Jun; 11(11):941-8. PubMed ID: 14985787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambient particulate matter directs nonclassic dendritic cell activation and a mixed TH1/TH2-like cytokine response by naive CD4+ T cells.
    Williams MA; Porter M; Horton M; Guo J; Roman J; Williams D; Breysse P; Georas SN
    J Allergy Clin Immunol; 2007 Feb; 119(2):488-97. PubMed ID: 17187851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA.
    Tsujimoto H; Efron PA; Matsumoto T; Ungaro RF; Abouhamze A; Ono S; Mochizuki H; Moldawer LL
    Immunol Lett; 2006 Nov; 107(2):155-62. PubMed ID: 17011046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming.
    Kovarik J; Bozzotti P; Love-Homan L; Pihlgren M; Davis HL; Lambert PH; Krieg AM; Siegrist CA
    J Immunol; 1999 Feb; 162(3):1611-7. PubMed ID: 9973420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells.
    Lee JS; Kim SG; Kim HK; Lee TH; Jeong YI; Lee CM; Yoon MS; Na YJ; Suh DS; Park NC; Choi IH; Kim GY; Choi YH; Chung HY; Park YM
    J Cell Physiol; 2007 Feb; 210(2):385-97. PubMed ID: 17058260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS.
    Skokos D; Nussenzweig MC
    J Exp Med; 2007 Jul; 204(7):1525-31. PubMed ID: 17576775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells.
    Latchumanan VK; Balkhi MY; Sinha A; Singh B; Sharma P; Natarajan K
    Tuberculosis (Edinb); 2005; 85(5-6):377-83. PubMed ID: 16246624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells.
    Krumbiegel D; Zepp F; Meyer CU
    Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling in B cells via Toll-like receptors.
    Peng SL
    Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
    Henault M; Lee LN; Evans GF; Zuckerman SH
    J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis.
    Oberholzer A; Oberholzer C; Efron PA; Scumpia PO; Uchida T; Bahjat K; Ungaro R; Tannahill CL; Murday M; Bahjat FR; Tsai V; Hutchins B; Moldawer LL; Laface D; Clare-Salzler MJ
    Shock; 2005 Jun; 23(6):507-15. PubMed ID: 15897802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells.
    Singh V; Agrewala JN
    BMC Immunol; 2006 Aug; 7():17. PubMed ID: 16889674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R; Roberts TL; Stacey KJ; Lenert P
    Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells.
    Mascarell L; Lombardi V; Louise A; Saint-Lu N; Chabre H; Moussu H; Betbeder D; Balazuc AM; Van Overtvelt L; Moingeon P
    J Allergy Clin Immunol; 2008 Sep; 122(3):603-9.e5. PubMed ID: 18774396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.